Trial Profile
Transdermal testosterone gel for poor ovarian responders. A multicenter double-blind placebo controlled randomized trial
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Oct 2023
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms T-TRANSPORT
- 09 Oct 2023 This trial has been discontinued in Spain (End Date: 18 Nov 2022), according to European Clinical Trials Database record.
- 25 Sep 2023 This trial has been discontinued in Denmark, according to European Clinical Trials Database record.
- 16 Jul 2023 This trial has been completed in Spain, according to European Clinical Trials Database record. (End date: 11 Jul, 2023)